Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT

ObjectiveGastrointestinal stromal tumors (GISTs) and malignant lymphomas (MLs) in the abdomen are often observed as tumors of unknown origin on F-18 FDG PET/CT. The purpose of this study was to evaluate the intratumoral metabolic heterogeneity of F-18 FDG uptake on PET to determine if it might be helpful to discriminate between these tumors.MethodsThe F-18 FDG PET/CT findings of 21 large abdominal tumors were retrospectively evaluated (9 GISTs and 12 MLs). Intratumoral heterogeneity was evaluated by visual scoring (visual score: 0, homogeneous; 1, slightly heterogeneous; 2, moderately heterogeneous; 3, highly heterogeneous) and by the cumulative standardized uptake value (SUV) histograms on transaxial PET images at the maximal cross-sectional tumor diameter. Percent tumor areas above a threshold from 0 to 100% of the maximum SUV were plotted and the area under curve of the cumulative SUV histograms (AUC-CSH) was used as a heterogeneity index, where lower values corresponded with increased heterogeneity. Correlation between the visual score and the AUC-CSH was investigated by the Spearman’s rank test.ResultsGISTs exhibited heterogeneous uptake of F-18 FDG, whereas MLs showed rather homogeneous uptake on visual analysis (visual score: 2.67 ± 0.50 and 0.58 ± 0.79, respectively; p < 0.001). The AUC-CSH was significantly lower for the GISTs than for the MLs (0.41 ± 0.14 and 0.64 ± 0.08, respectively; p < 0.001). Significant correlations were observed between the visual score and the AUC-CSH (ρ = −0.866, p < 0.001).ConclusionGISTs exhibited significantly heterogeneous intratumoral tracer uptake as compared with the MLs. Evaluation of the intratumoral heterogeneity of F-18 FDG uptake may help in the discrimination between these tumors.

[1]  M. Hatt,et al.  Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.

[2]  Finbarr O'Sullivan,et al.  A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data. , 2003, Biostatistics.

[3]  Y. Erdi,et al.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Laurini,et al.  Gastrointestinal stromal tumors: a review of the literature. , 2010, Archives of pathology & laboratory medicine.

[5]  P. Manoharan,et al.  Imaging in gastrointestinal stromal tumours: current status and future directions. , 2010, Clinical radiology.

[6]  S. H. Kim,et al.  Small gastrointestinal stromal tumours with focal areas of low attenuation on CT: pathological correlation. , 2005, Clinical radiology.

[7]  S. Basu,et al.  FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor , 2008, Nuclear medicine communications.

[8]  M. Anis,et al.  Imaging of abdominal lymphoma. , 2008, Radiologic clinics of North America.

[9]  C Clifton Ling,et al.  Dependence of FDG uptake on tumor microenvironment. , 2005, International journal of radiation oncology, biology, physics.

[10]  C. Siu,et al.  Imaging of gastrointestinal stromal tumour (GIST). , 2004, Clinical radiology.

[11]  S. Coupland The challenge of the microenvironment in B‐cell lymphomas , 2011, Histopathology.

[12]  Ronald Boellaard,et al.  Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  S. de Vos,et al.  The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. , 2008, Radiologic clinics of North America.

[14]  A. Drevelegas,et al.  Gastrointestinal stromal tumors: a pictorial review. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[15]  K. Karube,et al.  Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances , 2005, Leukemia.